Annechien Plat

1.5k total citations
33 papers, 1.0k citations indexed

About

Annechien Plat is a scholar working on Immunology, Oncology and Obstetrics and Gynecology. According to data from OpenAlex, Annechien Plat has authored 33 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Immunology, 18 papers in Oncology and 8 papers in Obstetrics and Gynecology. Recurrent topics in Annechien Plat's work include Cancer Immunotherapy and Biomarkers (16 papers), Immunotherapy and Immune Responses (10 papers) and Immune Cell Function and Interaction (9 papers). Annechien Plat is often cited by papers focused on Cancer Immunotherapy and Biomarkers (16 papers), Immunotherapy and Immune Responses (10 papers) and Immune Cell Function and Interaction (9 papers). Annechien Plat collaborates with scholars based in Netherlands, United Kingdom and Switzerland. Annechien Plat's co-authors include Hans W. Nijman, Marco de Bruyn, Fenne L. Komdeur, Gert N. Moll, Harry Hollema, Hagma H. Workel, G. Bea A. Wisman, Anneke Kuipers, Rick Rink and Maartje C.A. Wouters and has published in prestigious journals such as Journal of Clinical Oncology, Molecular and Cellular Biology and Applied and Environmental Microbiology.

In The Last Decade

Annechien Plat

31 papers receiving 1.0k citations

Peers

Countries citing papers authored by Annechien Plat

Since Specialization

Citations

This map shows the geographic impact of Annechien Plat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Annechien Plat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Annechien Plat more than expected).

Fields of papers citing papers by Annechien Plat

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Annechien Plat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Annechien Plat. The network helps show where Annechien Plat may publish in the future.

Co-authorship network of co-authors of Annechien Plat

This figure shows the co-authorship network connecting the top 25 collaborators of Annechien Plat. A scholar is included among the top collaborators of Annechien Plat based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Annechien Plat. Annechien Plat is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Vvax001, a Therapeutic Vaccine, for Patients with HPV16-Positive High-grade Cervical Intraepithelial Neoplasia: A Phase II Trial 2025 ·Clinical Cancer Research ·(unknown), (unknown), (unknown), Annegé Vledder, Nienke van Rooij, Annechien Plat, (unknown), Sterre T. Paijens, Lorian Slagter‐Menkema, Ed Schuuring, (unknown), Jos G. W. Kosterink, Bart‐Jan Kroesen, Jan Wilschut, Toos Daemen, Joost Bart, Hans W. Nijman, Marco de Bruyn, Refika Yigit	4
2	Spatiotemporal Immune Landscape and Long-term Immune Memory in POLE-Mutant Endometrial Cancer at the Single-Cell Level 2025 ·Cancer Immunology Research ·(unknown), Marta Requesens, Nienke van Rooij, Hagma H. Workel, (unknown), Annechien Plat, René Wardenaar, Diana C.J. Spierings, Floris Foijer, David N. Church, Joost Bart, Hans W. Nijman, Marco de Bruyn	0
3	IL-6R expression is an independent prognostic factor in high-grade serous ovarian cancer 2025 ·PubMed ·(unknown), Annegé Vledder, Sterre T. Paijens, Annechien Plat, Floris Foijer, Hans W. Nijman, Marco de Bruyn	0
4	B cells critical for outcome in high grade serous ovarian carcinoma 2024 ·International Journal of Cancer ·Annegé Vledder, Sterre T. Paijens, (unknown), (unknown), Evelien W. Duiker, (unknown), (unknown), Mathilde Jalving, (unknown), Nienke van Rooij, Annechien Plat, G. Bea A. Wisman, (unknown), Thijs Roelofsen, (unknown), (unknown), Viktor H. Koelzer, Marco de Bruyn, Hans W. Nijman	1
5	Design, Synthesis, and Biological Evaluation of 2-Hydroxy-4-phenylthiophene-3-carbonitrile as PD-L1 Antagonist and Its Comparison to Available Small Molecular PD-L1 Inhibitors 2023 ·Journal of Medicinal Chemistry ·(unknown), Roberto Butera, Marta Requesens, Annechien Plat, Tryfon Zarganes‐Tzitzikas, Constantinos G. Neochoritis, Jacek Plewka, Łukasz Skalniak, Justyna Kocik-Krol, Bogdan Musielak, Katarzyna Magiera‐Mularz, (unknown), (unknown), Marco de Bruyn, Hans W. Nijman, Philip H. Elsinga, Tad A. Holak, Alexander Dömlingꝉ	9
6	Development of [89Zr]Zr-hCD103.Fab01A and [68Ga]Ga-hCD103.Fab01A for PET imaging to noninvasively assess cancer reactive T cell infiltration: Fab-based CD103 immunoPET 2023 ·EJNMMI Research ·(unknown), (unknown), Arjan Kol, (unknown), (unknown), Sander M. J. van Duijnhoven, Annechien Plat, Hans van Eenennaam, Philip H. Elsinga, Hans W. Nijman, Marco de Bruyn	2
7	Expression of CD39 Identifies Activated Intratumoral CD8+ T Cells in Mismatch Repair Deficient Endometrial Cancer 2022 ·Cancers ·Joyce M. Lubbers, (unknown), Nienke van Rooij, Arjan Kol, Hagma H. Workel, Annechien Plat, Sterre T. Paijens, (unknown), Diana C.J. Spierings, Philip H. Elsinga, Edwin Bremer, Hans W. Nijman, Marco de Bruyn	4
8	Tumor infiltrating CD8/CD103/TIM-3-expressing lymphocytes in epithelial ovarian cancer co-express CXCL13 and associate with improved survival 2022 ·Frontiers in Immunology ·(unknown), (unknown), (unknown), (unknown), Annechien Plat, Gerwin Huls, Hans W. Nijman, Marco de Bruyn, Edwin Bremer	11
9	Development of ⁸⁹Zr-anti-CD103 PET imaging for non-invasive assessment of cancer reactive T cell infiltration 2022 ·Journal for ImmunoTherapy of Cancer ·Arjan Kol, (unknown), (unknown), Sander M. J. van Duijnhoven, Danique Giesen, Annechien Plat, Hans van Eenennaam, Philip H. Elsinga, Hans W. Nijman, Marco de Bruyn	4
10	Prognostic Integrated Image-Based Immune and Molecular Profiling in Early-Stage Endometrial Cancer 2020 ·Cancer Immunology Research ·Nanda Horeweg, Marco de Bruyn, Remi A. Nout, Ellen Stelloo, (unknown), Alicia León‐Castillo, Annechien Plat, Kirsten D. Mertz, (unknown), Ina M. Jürgenliemk‐Schulz, Ludy Lutgens, Jan J. Jobsen, Elzbieta M. van der Steen‐Banasik, Vincent T.H.B.M. Smit, Carien L. Creutzberg, Tjalling Bosse, Hans W. Nijman, Viktor H. Koelzer, David N. Church	42
11	Transcriptional Activity and Stability of CD39+CD103+CD8+ T Cells in Human High-Grade Endometrial Cancer 2020 ·International Journal of Molecular Sciences ·Hagma H. Workel, Nienke van Rooij, Annechien Plat, Diana C.J. Spierings, Rudolf S.N. Fehrmann, Hans W. Nijman, Marco de Bruyn	14
12	A Transcriptionally Distinct CXCL13+CD103+CD8+ T-cell Population Is Associated with B-cell Recruitment and Neoantigen Load in Human Cancer 2019 ·Cancer Immunology Research ·Hagma H. Workel, Joyce M. Lubbers, Roland Arnold, Thalina M. Prins, Pieter van der Vlies, Kim de Lange, Tjalling Bosse, Inge C. van Gool, Florine A. Eggink, Maartje C.A. Wouters, Fenne L. Komdeur, Elisabeth C. van der Slikke, Carien L. Creutzberg, Arjan Kol, Annechien Plat, Mark A. Glaire, David N. Church, Hans W. Nijman, Marco de Bruyn	167
13	L1CAM expression in uterine carcinosarcoma is limited to the epithelial component and may be involved in epithelial–mesenchymal transition 2018 ·Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin ·Marco Versluis, Annechien Plat, Marco de Bruyn, Xavier Matías‐Guiu, (unknown), Camilla Krakstad, (unknown), Tjalling Bosse, Geertruida H. de Bock, Harry Hollema	10
14	CD103+ tumor-infiltrating lymphocytes are tumor-reactive intraepithelial CD8+ T cells associated with prognostic benefit and therapy response in cervical cancer 2017 ·OncoImmunology ·Fenne L. Komdeur, Thalina M. Prins, Stephanie van de Wall, Annechien Plat, G. Bea A. Wisman, Harry Hollema, Toos Daemen, David N. Church, Marco de Bruyn, Hans W. Nijman	129
15	The prognostic benefit of tumour-infiltrating Natural Killer cells in endometrial cancer is dependent on concurrent overexpression of Human Leucocyte Antigen-E in the tumour microenvironment 2017 ·European Journal of Cancer ·Marco Versluis, Samuel Marchal, Annechien Plat, Geertruida H. de Bock, Thorbald van Hall, Marco de Bruyn, H. Hollema, Hans W. Nijman	32
16	CD103 defines intraepithelial CD8+ PD1+ tumour-infiltrating lymphocytes of prognostic significance in endometrial adenocarcinoma 2016 ·European Journal of Cancer ·Hagma H. Workel, Fenne L. Komdeur, Maartje C.A. Wouters, Annechien Plat, Harry Klip, Florine A. Eggink, G. Bea A. Wisman, Henriëtte J.G. Arts, Maaike H.M. Oonk, Marian J.E. Mourits, Refika Yigit, Marco Versluis, Evelien W. Duiker, Harry Hollema, Marco de Bruyn, Hans W. Nijman	113
17	Treatment Regimen, Surgical Outcome, and T-cell Differentiation Influence Prognostic Benefit of Tumor-Infiltrating Lymphocytes in High-Grade Serous Ovarian Cancer 2015 ·Clinical Cancer Research ·Maartje C.A. Wouters, Fenne L. Komdeur, Hagma H. Workel, Harry Klip, Annechien Plat, (unknown), G. Bea A. Wisman, Marian J.E. Mourits, Henriëtte J.G. Arts, Maaike H.M. Oonk, Refika Yigit, Steven de Jong, Cornelis J.M. Melief, Harry Hollema, Evelien W. Duiker, Toos Daemen, Marco de Bruyn, Hans W. Nijman	56
18	Prediction model for regional or distant recurrence in endometrial cancer based on classical pathological and immunological parameters 2015 ·British Journal of Cancer ·Marco Versluis, Renske A. de Jong, Annechien Plat, Tjalling Bosse, Vincent T.H.B.M. Smit, Helen Mackay, Melanie Powell, Alexandra Léary, Linda Mileshkin, Henry C Kitchener, Emma J. Crosbie, Richard J. Edmondson, Carien L. Creutzberg, Harry Hollema, Toos Daemen, Geertruida H. de Bock, Hans W. Nijman	23
19	Mechanistic Aspects of Lanthipeptide Leaders 2013 ·Current Protein and Peptide Science ·Annechien Plat, Anneke Kuipers, Rick Rink, Gert N. Moll	33
20	Requirements of the Engineered Leader Peptide of Nisin for Inducing Modification, Export, and Cleavage 2010 ·Applied and Environmental Microbiology ·Annechien Plat, Leon Kluskens, Anneke Kuipers, Rick Rink, Gert N. Moll	84

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact